Administered by deep intramuscular injection or by intravenous infusion over 30 minutes. Reconstitute the powder with an appropriate diluent (e.g., Sterile Water for Injection, 0.9% Sodium Chloride Injection).

Cefepime is a bactericidal antibiotic that acts by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), disrupting peptidoglycan synthesis, leading to bacterial cell lysis and death.

• •Known hypersensitivity to cefepime, any other cephalosporin, penicillins, or any other beta-lactam antibiotic.
• •History of severe hypersensitivity reaction to any component of the formulation.

Store below 25-30°C. Protect from light. Keep out of the reach of children. Do not freeze the powder.

In case of overdose, symptoms may include encephalopathy (e.g., convulsions, confusion, stupor), myoclonus, and neuromuscular excitability. Treatment should be symptomatic and supportive. Hemodialysis can remove cefepime from the body.

**Pregnancy Category B:** Studies in animals have shown no evidence of harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if clearly needed. **Lactation:** Cefepime is excreted in human milk in very low concentrations. Caution should be exercised when administered to a nursing woman.